Article
AFD China Newsletter - July, 2025
Under the joint witness of Chinese President Xi Jinping and Kazakh President Kassym-Jomart Tokayev, the China National Intellectual...
AFD China
China: Food and Drugs Law
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
China On The Move: China's Healthcare And Life Sciences Regulatory Evolution In 2025
In the first half of 2025, China's healthcare and life sciences regulatory framework underwent a wave of important reforms. These developments reflect the country's continued efforts toward global alignment...
Greenberg Traurig, LLP
Article
China Compliance Update – Summer 2025
Anti-corruption has remained an area of focus area for Chinese authorities in the first half of 2025, with major legislative updates and enforcement cases.
Arnold & Porter
Article
Analysing Key Trends In China's Patent-linkage System And Their Impact On Pharmaceutical Patent Strategies
In recent years, China has emerged as a significant global player in the pharmaceutical sector, not only due to its vast market potential but also because of its evolving intellectual property (IP) framework.
CCPIT Patent & Trademark Law Office
Article
The Regulatory Data Protection Regime In China (Draft For Comments)
Fangda Partners
Article
澳门特区专利药品及植物药剂产品保护补充证明书制度解析
CCPIT Patent & Trademark Law Office
Article
中国创新药械全球崛起法律保障系列文章之一：创新药研发企业临床试验数据对外跨境传输的监管要点
AnJie Broad Law Firm
Article
China Advances Pharmaceutical Data Protection Regime With New Draft Measures
A&O Shearman
Article
马库什化合物专利申请中，这4个缺陷一定要规避！
Kangxin
Article
China Introduces A New Regulatory Data Protection And Exclusivity Mechanism
Arnold & Porter
Article
Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations
AnJie Broad Law Firm
Article
Six Key Insights Into China Biotech's NewCo Model
Han Kun Law Offices
Article
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: AstraZeneca
Rouse
Article
CN 2025 Drafts On Clinical Trial Data Exclusivity
Toby Mak
Article
中国、完全なAI産業体系を形成 AI特許出願件数が世界1位
Kangxin
Article
2025香港稳定币牌照申请深度剖析（下）
Tian Yuan Law Firm
Article
《实施〈中华人民共和国反外国制裁法〉的规定》要点解读和实务建议
Shanghai YaoWang Law Offices
Article
PRC Financial Regulation: Annual Report (2024) - Banking
Fangda Partners
Article
试管婴儿辅助生殖行业法律问题探究
AnJie Broad Law Firm
Article
转用发明创造性浅析
专利审查指南第二部分第四章第4.4节规定了转用发明创造性判断的考量因素...
CCPIT Patent & Trademark Law Office
Article
从"AB酶"系列案件看商标法第十条一款七项的适用
商标法第十条第一款第七项规定，下列标志不得作为商标注册：（七）带有欺骗性，容易使公众对商品的质量等特点或者产地产生误认的。
CCPIT Patent & Trademark Law Office
Article
《关于药品领域的反垄断指南》解读：药企反垄断风险"划重点"
2025年1月23日，国务院反垄断反不正当竞争委员会正式发布了《关于药品领域的反垄断指南》（"《指南》正式稿"）。从2024年8月9日发布征求意见稿到2025&
AnJie Broad Law Firm
Article
Application Of Bioisosterism In The Judgment Of Inventiveness
When determining whether the replacement between two groups in a pharmaceutical compound is common knowledge in the art, bioisosterism may generally be considered.
AFD China
Article
東陽光薬、中国特許金賞を受賞 国際特許出願で世界展開を加速
Kangxin
Article
China On The Move: Lessons From China's 2024 National Negotiation Of Drug Prices
Greenberg Traurig, LLP
Article
CN Final Antimonopoly Guidelines For The Pharmaceutical Sector
Toby Mak
Article
China Unveils New Anti-Monopoly Guidelines For The Pharmaceutical Sector
Jones Day
Article
China Life Sciences: 2024 Year In Review
Arnold & Porter
Article
医药企业申请商标的注意事项
CCPIT Patent & Trademark Law Office
Article
China Announces Major Policy Incentives For Life Sciences Companies
Ropes & Gray LLP
Article
中美两国药品专利链接制度的比较
CCPIT Patent & Trademark Law Office
Article
26 Noteworthy Things About China's PTA And PTE System
NTD Patent & Trademark Agency
Article
Measures For Supervision And Administration Of The Quality Of Drug Supply And Use
CMS, China
Article
China Announces Major Policy Incentives For Life Sciences Companies
On December 30, 2024, China's State Council published a series of policy incentives in Circular No. 53 to stimulate the transformation of the country's life sciences industry.
Ropes & Gray LLP
Article
中美两国药品专利链接制度的比较
药品专利链接制度是指仿制药...
CCPIT Patent & Trademark Law Office
Article
26 Noteworthy Things About China's PTA And PTE System
The number of patents eligible for Patent Term Extension in China each year is tiny. But for any patentee having the opportunity to request for PTE, however, it's a big deal that could be worth...
NTD Patent & Trademark Agency
Article
Measures For Supervision And Administration Of The Quality Of Drug Supply And Use
To implement the Drug Administration Law of the PRC, a draft version of the Measures for Supervision and Administration of Drug Supply was publicized in September 2019 for public opinion
CMS, China
Article
Cannabis Law And Legislation In China
CMS, China
Article
FDA Accepts BLA For Shanghai Henlius Biotech's And Organon's HLX14, A Denosumab Biosimilar
On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab).
Goodwin Procter LLP
Article
干细胞与基因治疗领域扩大开放新政及CAR-T地方监管新规初探
近年来细胞和基因治疗（CGT）领域随着相关科学理论、技术手段和临床医疗实践的不断演进而蓬勃发展。
AnJie Broad Law Firm
Article
China's NMPA Announces A Pilot Plan To Allow Non-End-To-End Manufacturing Of Biologics
On October 21, 2024, the China National Medical Products Administration (NMPA) released a pilot plan that allows non-end-to-end manufacturing of biologics. The NMPA has a longstanding position to require an end-to-end...
Ropes & Gray LLP
Article
Patent Term Extensions In China: Overviews And Takeaways
China has developed rapidly in the pharmaceutical industry in the past few years and has become one of the largest and most active pharmaceutical markets in the world.
CCPIT Patent & Trademark Law Office
Article
BIOSECURE Act: Anticipated Movement, Key Provisions, And Likely Impact
Foley & Lardner
Article
China Expands Pilot Program For Foreign Investment In The Healthcare Sector
Sheppard Mullin Richter & Hampton
Article
对药品专利权期限补偿的解析和思考
CCPIT Patent & Trademark Law Office
Article
China Proposed New Anti-Monopoly Guidelines For The Pharmaceutical Sector
Sheppard Mullin Richter & Hampton
Article
중국 국가지식산권국장, 외국인 투자기업과 지식재산권 보호에 관해 논의
Kangxin
Article
CNIPA And Italy's Ministry Of Agriculture, Food Sovereignty And Forestry Sign MoU On Geographical Indications
AFD China
Article
The Demand And Challenges Of Patent Protection For Combination Drug Therapy
Lung Tin IP Attorneys
Article
Revisions Of The Implementing Regulations Of The Patent Law And The Patent Examination Guidelines: Comments On Several Key Issues
Lung Tin IP Attorneys
Article
"保险+互联网医疗"业态的合规要点
AnJie Broad Law Firm
Article
"互联网+医疗"领域的主要业务类型及其关注热点（续）Q&A
AnJie Broad Law Firm
Article
China And France Renew Protocol For Cooperation On Agricultural And Food Geographical Indications
AFD China
Article
医药许可与BD合作交易近期常见争议及对交易文件起草的启示
AnJie Broad Law Firm
Article
药品许可交易概览及核心法律条款
AnJie Broad Law Firm
Article
Commission Makes First Use Of IPI, Targeting Medical Device Procurement Markets In China
Van Bael & Bellis
Article
中医薬基盤モデル「デジタル・スマート本草」が天津で発表
Kangxin